ArticleThe Pan African medical journal2025
Risk factors for hypertension in patients with type 2 diabetes mellitus in the Casablanca-Settat region, Morocco: a cross-sectional study.
Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From guidelines to practice: an Egyptian expert opinion on type 2 diabetes mellitus management in primary care settings.BMC primary care · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: hypertension in patients with type 2 diabetes mellitus (T2DM) is a major problem that increases the risk of morbidity and mortality. Although the prevalence of this disease is high in the T2DM population, the risk factors for it remain understudied. The objective of this study is to identify the risk factors combined with hypertension in Moroccan patients with T2DM. Methods: this cross-sectional study was conducted between January 2017 and July 2018 in primary healthcare centers. A total of 503 T2DM patients were included. Inclusion criteria: adults (≥18 years) with T2DM for ≥1 year. Exclusion criteria: type 1 diabetes, gestational diabetes, cognitive impairment, or missing data. Data on demographics, clinical history, and biochemical markers were analyzed using SPSS. Logistic regression identified independent risk factors, reported as adjusted OR with 95% CI. A p-value <0.05 was considered statistically significant. Results: a total of 503 patients with T2DM were included (71% female, 29% male), with a mean age of 58.4 ± 10.2 years. The prevalence of hypertension was 70.2%. Patients with hypertension were significantly older (mean age: 61.2 ± 9.8 years vs. 52.6 ± 10.5 years, p ≤ 0.001). The most common cardiovascular risk factors were dyslipidemia (54.1%), obesity (mean BMI: 30.8 ± 5.6 kg/m Conclusion: in this study, we found that hypertension is highly prevalent among patients with T2DM. Our findings indicate that older age, longer diabetes duration, therapeutic modifications, dyslipidemia, and higher BMI levels are significant risk factors for diabetes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.